Table of Contents
Introduction
Placenta Accreta Spectrum (PAS) disorders comprise a range of conditions characterized by abnormal placental attachment to the uterine wall. The spectrum includes several forms: placenta accreta, where the placenta attaches too deeply without invading the myometrium; placenta increta, which involves partial invasion into the myometrium; and placenta percreta, where the placenta invades through the entire uterine wall and may penetrate nearby organs. The incidence of PAS has surged dramatically due to the rising rates of cesarean deliveries and uterine interventions, underscoring the need for effective management strategies.
Causes and Types of Placenta Accreta Spectrum Disorders
The pathogenesis of PAS is closely linked to prior uterine surgeries, such as cesarean sections, which lead to scarring and inadequate decidualization. Women with a history of multiple cesarean deliveries are particularly at risk. The FIGO (International Federation of Gynecology and Obstetrics) classification system categorizes PAS into three grades:
- Grade 1 (G1): Abnormally adherent placenta (placenta adherenta or creta).
- Grade 2 (G2): Abnormally invasive placenta (increta).
- Grade 3 (G3): Abnormally invasive placenta (percreta), with further subdivisions based on the extent of invasion into adjacent structures.
Table 1: Types of Placenta Accreta Spectrum Disorders
| Type | Description | Risk Factors |
|---|---|---|
| Accreta | Placenta adheres to the myometrium without invasion | Previous uterine surgery, placenta previa |
| Increta | Placenta invades the myometrium | Multiple cesarean deliveries, uterine scarring |
| Percreta | Placenta invades through the uterine wall, possibly invading organs | Previous surgeries, abnormal placentation |
Clinical Implications and Risks Associated with PAS
The clinical implications of PAS are significant, often leading to severe maternal morbidity and mortality. The risk of hemorrhage is particularly high, with rates of blood loss exceeding 4,000 mL in severe cases. The potential for complications such as disseminated intravascular coagulation (DIC) and multisystem organ failure further complicates management. Notably, the mortality rate can reach up to 1.4% in cases of placenta percreta, emphasizing the necessity for early diagnosis and comprehensive preoperative planning.
Table 2: Complications Associated with Placenta Percreta
| Complication | Incidence | Description |
|---|---|---|
| Hemorrhage | 7-10% | Severe blood loss during delivery or surgery |
| Bladder injury | 13-44% | Urinary tract injuries due to adhesion to the placenta |
| DIC | 1.4% | A life-threatening condition due to severe bleeding |
| Extended ICU stay | Varies | Prolonged recovery and monitoring in critical care settings |
Diagnostic Techniques for Early Detection of PAS
Early detection of PAS is crucial for optimizing outcomes. Antenatal imaging, particularly through ultrasound and MRI, plays a vital role in identifying the condition. The presence of vascular lacunae, irregular bladder walls, and abnormal myometrial interfaces are key ultrasound findings suggestive of PAS. The FIGO risk scoring system is utilized to stratify patients, guiding the complexity of required interventions.
Table 3: Diagnostic Imaging Techniques for PAS
| Technique | Advantages | Limitations |
|---|---|---|
| Ultrasound | Non-invasive, widely available | Operator-dependent accuracy |
| MRI | Detailed visualization of placental invasion | Higher cost, requires specialized facilities |
Surgical Management Strategies for Placenta Accreta
Surgical management of PAS is often complicated and may necessitate a range of techniques based on the severity of the condition. The preferred approach is a planned cesarean hysterectomy, typically performed between 34-35 weeks of gestation in a tertiary care center with multidisciplinary support. For cases identified intraoperatively, emergency interventions may be required, including radical hysterectomy or even ligation of the internal iliac arteries to control hemorrhage.
Table 4: Surgical Management Strategies
| Procedure | Description | Indication |
|---|---|---|
| Planned Hysterectomy | Scheduled surgery to remove uterus with placenta in situ | Antenatal diagnosis of PAS |
| Emergency Hysterectomy | Unplanned surgery due to acute hemorrhage | Intraoperative diagnosis of PAS |
| Uterine Artery Ligation | Control bleeding by occluding uterine arteries | Severe hemorrhage during surgery |
Outcomes of Multidisciplinary Approaches in PAS Treatment
Multidisciplinary management involving obstetricians, anesthesiologists, and interventional radiologists is essential for improving outcomes in PAS patients. The integration of advanced imaging techniques, preoperative planning, and intraoperative strategies significantly reduces complications and enhances recovery. Studies have shown that patients undergoing planned cesarean hysterectomy experience lower blood loss and fewer complications compared to emergency procedures.
Table 5: Outcomes of Multidisciplinary Management
| Outcome | Planned Hysterectomy | Emergency Hysterectomy |
|---|---|---|
| Estimated Blood Loss | 1,561 mL | 2,772 mL |
| Rate of Coagulopathy | 6% | 40% |
| Bladder Injury Rate | 13% | 44% |
FAQs
What is the primary cause of Placenta Accreta Spectrum? The primary cause of PAS is often related to prior uterine surgeries, especially cesarean sections, which lead to abnormal placental attachment.
How is PAS diagnosed? PAS is diagnosed through imaging techniques like ultrasound and MRI, which help visualize placental attachment and invasion.
What are the treatment options for PAS? Treatment options include planned cesarean hysterectomy, emergency hysterectomy, and sometimes uterine artery ligation to control bleeding.
What are the risks associated with PAS? Risks include severe hemorrhage, bladder injury, DIC, and possible maternal mortality, highlighting the need for early diagnosis and surgical intervention.
How can PAS be prevented? Preventive measures include careful monitoring of pregnancies with a history of uterine surgeries and planning deliveries in specialized centers.
References
- ACOG. (2021). Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Retrieved from https://doi.org/10.7759/cureus.85028
- Burton, G. J., & Fowden, A. L. (2015). The placenta: A transient organ. Human Reproduction Update, 21(5), 579-594. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12221538/
- Nouri, B., Talebian, N., Kharaz, L., & Falah Tafti, M. (2025). Diagnostic value of serum cancer antigen 125, carcinoembryonic antigen, cancer antigen 19-9, anti Müllerian hormone, white blood cell count, platelet count, and neutrophil to lymphocyte ratio in endometriosis: A retrospective study. Int J Fertil Steril, 19(3), 259-263. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12206352/
- Yang, X., & Feng, Q. (2025). ALKBH5 regulates intrauterine adhesion progression through m6A dependent FABP4 mRNA stabilization and serum lipid metabolism. Communications Biology, 10, 75. Retrieved from https://doi.org/10.1038/s42003-025-08375-3
- Baeza, I., de la Serna, E., & Dolz, M. (2025). Impact of obstetric complications in subjects at clinical high risk for psychosis: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 152(1), 16-25. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12213012/
- Li, Y., et al. (2025). Sperm metabolomic signatures of asthenozoospermia and teratozoospermia in Chinese reproductive-age men. Scientific Reports, 15, 79. Retrieved from https://doi.org/10.1038/s41598-025-09787-1
- Costanzo, G., et al. (2020). A Rare Case of a Hypervascular Placental Polyp Leading to Massive Postpartum Hemorrhage Requiring Hysterectomy. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12221538/
- Cheng, V., et al. (2025). Pregnancy Outcomes of Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review. Arthritis Care Res, 77(7), 979-985. Retrieved from https://pubmed.ncbi.nlm.nih.gov/12209491/